Gammaretroviral vector encoding a fluorescent marker to facilitate detection of reprogrammed human fibroblasts during iPSC generation

PeerJ

Volumn 2013, Issue 1, 2013, Pages

  Srinivasakumar, Narasimhachar ^a   Zaboikin, Michail ^a   Tidball, Andrew M ^b   Aboud, Asad A ^b   Neely, M Diana ^b   Ess, Kevin C ^b   Bowman, Aaron B ^b   Schuening, Friedrich G ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Detection; Gammaretrovirus; Induced pluripotent stem cells; IPSC; Reprogramming; Silencing

Indexed keywords

ALKALINE PHOSPHATASE;

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; EMBRYOID BODY; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KARYOTYPING; LONG TERMINAL REPEAT; NUCLEOTIDE SEQUENCE; PHASE CONTRAST MICROSCOPY; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84891507119     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.224     Document Type: Article

References (36)

1. Buta C, David R, Dressel R, Emgard M, Fuchs C, Gross U, Healy L, Hescheler J, Kolar R, Martin U, Mikkers H, Muller FJ, Schneider RK, Seiler AE, Spielmann H, Weitzer G. 2013. Reconsidering pluripotency tests: do we still need teratoma assays?. Stem Cell Research 11:552-562 DOI 10.1016/j.scr.2013.03.001.
2. Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O, Rho J, Ince TA, Daley GQ, Schlaeger TM. 2009. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nature Biotechnology 27:1033-1037 DOI 10.1038/nbt.1580.
3. Cherry SR, Biniszkiewicz D, van Parijs L, Baltimore D, Jaenisch R. 2000. Retroviral expression in embryonic stem cells and hematopoietic stem cells. Molecular and Cellular Biology 20:7419-7426 DOI 10.1128/MCB.20.20.7419-7426.2000.
4. Flanagan JR, Krieg AM, Max EE, Khan AS. 1989. Negative control region at the 50 end of murine leukemia virus long terminal repeats. Molecular and Cellular Biology 9:739-746.
5. Hanna J, Saha K, Pando B, van Zon J, Lengner CJ, Creyghton MP, van Oudenaarden A, Jaenisch R. 2009. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462:595-601 DOI 10.1038/nature08592.
6. Hilberg F, Stocking C, Ostertag W, Grez M. 1987. Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America 84:5232-5236 DOI 10.1073/pnas.84.15.5232.
7. Hotta A, Cheung AYL, Farra N, Garcha K, Chang WY, Pasceri P, Stanford WL, Ellis J. 2009a. EOS lentiviral vector selection system for human induced pluripotent stem cells. Nature Protocols 4:1828-1844 DOI 10.1038/nprot.2009.201.
8. Hotta A, Cheung AYL, Farra N, Vijayaragavan K, S Eacute Guin CA, Draper JS, Pasceri P, Maksakova IA, Mager DL, Rossant J, Bhatia M, Ellis J. 2009b. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nature Methods 6:370 DOI 10.1038/nmeth.1325.
9. Hotta A, Ellis J. 2008. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. Journal of Cellular Biochemistry 105:940-948 DOI 10.1002/jcb.21912.
10. Jaenisch R, Young R. 2008. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132:567-582 DOI 10.1016/j.cell.2008.01.015.
11. Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Li Z, Panetta NJ, Chen ZY, Robbins RC, Kay MA, Longaker MT, Wu JC. 2010. A nonviral minicircle vector for deriving human iPS cells. Nature Methods 7:197-199 DOI 10.1038/nmeth.1426.
12. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS. 2009. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:472-476 DOI 10.1016/j.stem.2009.05.005.
13. Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T, Kumagai H. 2003. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Experimental Hematology 31:1007-1014.
14. Liang G, Zhang Y. 2013. Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Cell Research 23:49-69 DOI 10.1038/cr.2012.175.
15. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K. 2007. Directly reprogrammed fibroblastsshow global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70 DOI 10.1016/j.stem.2007.05.014.
16. Minoguchi S, Iba H. 2008. Instability of retroviral DNA methylation in embryonic stem cells. Stem Cells 26:1166-1173 DOI 10.1634/stemcells.2007-1106.
17. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. 2008. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology 26:101-106 DOI 10.1038/nbt1374.
18. Neely MD, Tidball AM, Aboud AA, Ess KC, Bowman AB. 2011. Induced Pluripotent Stem Cells (iPSCs): an emerging model system for the study of human neurotoxicology. vol. 56. Totowa, NJ: Humana Press, 27-61.
19. Ohnuki M, Takahashi K, Yamanaka S. 2009. Generation and characterization of human induced pluripotent stem cells. Current Protocols in Stem Cell Biology 9:4A.2.1-4A.2.25 DOI 10.1002/9780470151808.sc04a02s9.
20. Okita K, Ichisaka T, Yamanaka S. 2007. Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317 DOI 10.1038/nature05934.
21. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K-I, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S. 2011. A more efficient method to generate integration-free human iPS cells. Nature Methods 8:409-412 DOI 10.1038/nmeth.1591.
22. Pannell D, Ellis J. 2001. Silencing of gene expression: implications for design of retrovirus vectors. Reviews in Medical Virology 11:205-217 DOI 10.1002/rmv.316.
23. Papapetrou EP, Tomishima MJ, Chambers SM, Mica Y, Reed E, Menon J, Tabar V, Mo Q, Studer L, Sadelain M. 2009. Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proceedings of the National Academy of Sciences 106:12759-12764 DOI 10.1073/pnas.0904825106.
24. Srinivasakumar N. 2002. Packaging cell system for lentivirus vectors: preparation and use. vol. 69. Totowa, NJ: Humana Press Inc., 275-302.
25. Stadtfeld M, Maherali N, Breault DT, Hochedlinger K. 2008. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2:230-240 DOI 10.1016/j.stem.2008.02.001.
26. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872 DOI 10.1016/j.cell.2007.11.019.
27. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676 DOI 10.1016/j.cell.2006.07.024.
28. Warlich E, Kuehle J, Cantz T, Brugman MH, Maetzig T, Galla M, Filipczyk AA, Halle S, Klump H, Scholer HR, Baum C, Schroeder T, Schambach A. 2011. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Molecular Therapy 19:782-789 DOI 10.1038/mt.2010.314.
29. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ. 2010. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7:618-630 DOI 10.1016/j.stem.2010.08.012.
30. Wikipedia. Propagation of uncertainty. Available at http://en.wikipedia.org/wiki/Propagation of uncertainty (accessed 5 November 2013).
31. Wolf D, GoffSP. 2007. TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 131:46-57 DOI 10.1016/j.cell.2007.07.026.
32. Yamanaka S. 2012. Induced pluripotent stem cells: past, present, and future. Stem Cell 10:678-684.
33. Yu J, Chau KF, Vodyanik MA, Jiang J, Jiang Y. 2011. Efficient feeder-free episomal reprogramming with small molecules. PLoS ONE 6:e17557 DOI 10.1371/journal.pone.0017557.
34. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. 2009. Human induced pluripotent stem cells free of vector and transgene sequences. Science (New York, NY) 324:797-801 DOI 10.1126/science.1172482.
35. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science (New York, NY) 318:1917-1920 DOI 10.1126/science.1151526.
36. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Scholer HR, Duan L, Ding S. 2009. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4(5):381-384 DOI 10.1016/j.stem.2009.04.005.